Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Accounts Payables: 2017-2019

Historic Accounts Payables for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $2.2 million.

  • Astria Therapeutics' Accounts Payables rose 105.92% to $2.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was $2.2 million, marking a year-over-year increase of 105.92%. This contributed to the annual value of $1.4 million for FY2018, which is 82.15% up from last year.
  • According to the latest figures from Q3 2019, Astria Therapeutics' Accounts Payables is $2.2 million, which was up 55.11% from $1.4 million recorded in Q2 2019.
  • Astria Therapeutics' Accounts Payables' 5-year high stood at $2.2 million during Q3 2019, with a 5-year trough of $773,000 in Q4 2017.
  • For the 3-year period, Astria Therapeutics' Accounts Payables averaged around $1.3 million, with its median value being $1.2 million (2017).
  • Its Accounts Payables has fluctuated over the past 5 years, first slumped by 61.80% in 2018, then surged by 105.92% in 2019.
  • Over the past 3 years, Astria Therapeutics' Accounts Payables (Quarterly) stood at $773,000 in 2017, then spiked by 82.15% to $1.4 million in 2018, then surged by 105.92% to $2.2 million in 2019.
  • Its Accounts Payables stands at $2.2 million for Q3 2019, versus $1.4 million for Q2 2019 and $1.6 million for Q1 2019.